Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00084903 · ClinicalTrials.gov registry record · NA
Fluorescence and Reflectance Spectroscopy During Colposcopy in Detecting Cervical Intraepithelial Neoplasia and Dysplasia in Healthy Participants With a History of Normal Pap Smears
A NA study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 1,070
- Enrollment target
NCT00084903: Completed NA study, sponsored by M.D. Anderson Cancer Center.
NCT00084903 is a NA study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 1,070 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00084903, a NA study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,070 participants
- Enrollment target
Study Summary
RATIONALE: New diagnostic procedures such as fluorescence and reflectance spectroscopy (shining light on tissue and measuring patterns of light reflected) may improve the ability to noninvasively detect cervical intraepithelial neoplasia and dysplasia. PURPOSE: This diagnostic trial is studying how well fluorescence and reflectance spectroscopy during colposcopy work in detecting cervical intraepithelial neoplasia and dysplasia in healthy participants with a history of normal Pap smears.
Interventions
- PROCEDURE Colposcopic biopsy
- PROCEDURE Light-Scattering Spectroscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,070 participants |
| Start Date | 1998-04 |
| Est. Completion | 2009-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00084903
The ClinicalTrials.gov registry entry for NCT00084903 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,070 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Colposcopic biopsy is the first listed.
NCT00084903 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00084903 about?
NCT00084903 is a clinical study titled "Fluorescence and Reflectance Spectroscopy During Colposcopy in Detecting Cervical Intraepithelial Neoplasia and Dysplasia in Healthy Participants With a History of Normal Pap Smears". RATIONALE: New diagnostic procedures such as fluorescence and reflectance spectroscopy (shining light on tissue and measuring patterns of light reflected) may improve the ability to noninvasively detect cervical intraepithelial neoplasia and dysplasia. PURPOSE: This diagnostic trial is studying how...
What is the current status of trial NCT00084903?
This trial is currently completed. It is a NA study. The enrollment target is 1,070 participants. The study started on 1998-04. Estimated completion is 2009-02.
What interventions are being tested in trial NCT00084903?
The interventions under investigation include: Colposcopic biopsy (PROCEDURE), Light-Scattering Spectroscopy (PROCEDURE).
Who is sponsoring clinical trial NCT00084903?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.